Xtrackers MSCI Global Sdg 3 Good Health UCITS ETF 1C
Xtrackers MSCI Global Sdg 3 Good Health UCITS ETF 1C is an exchange-traded fund (ETF) from Xtrackers, traded under the ticker SDG3 (ISIN IE00036F4K40). It lets you buy a basket of holdings in a single trade, spreading your money across them rather than one company. At its core it is a focused, thematic fund: it concentrates on the health care part of the market, so it lives or dies by that one area rather than the economy as a whole. Underneath, it is about owning small slices of companies, so you share in their growth when they do well — and their falls when they don't. Rather than a manager picking stocks, it simply replicates the MSCI Global Sdg 3 Good Health index — the passive, low-cost approach, and its largest holdings include ELI LILLY, ABBVIE INC and DANAHER CORP. With about 131 holdings (the ten largest ≈ 45.7%), your money is diversified rather than concentrated in a handful of names. Geographically it leans ~75.5% United States, ~6.6% United Kingdom and ~4.3% Denmark. Its heaviest sectors are ~97.8% Health Care and ~1.4% Consumer Staples. A focused fund like this is typically held as a smaller 'satellite' position around a broader core — a way to lean into one theme, not usually a portfolio's only holding. It holds the underlying investments directly (physical replication). Its price has swung about 44.4% over the past year, which describes how much its price tends to move rather than whether it is good. As with any investment, its value can go down as well as up, and past performance is not a guide to future results. (Fund data sourced from Xtrackers.)
Opens the screener with this filter applied.
About this fund
The MSCI Global Sdg 3 Good Health index is the benchmark this fund aims to copy. By holding it, this fund gives you a stake in around 131 companies across Global in a single purchase.
The fund actually buys every share in the index it tracks (full replication).
Fund facts
Performance
Growth of $100 invested — both lines start at $100.
Compared with the average fund tracking the same index — our own data, not the licensed index itself.
Return, year by year
How bumpy has it been?
The bigger picture
What's inside
By sector ?
By country ?
The 10 biggest holdings make up 45.7% of the fund — the rest is spread across roughly 121 more companies.
Top 10 holdings
| # | Company | Weight |
|---|---|---|
| 1 | ELI LILLY | 5.0% |
| 2 | ABBVIE INC | 4.9% |
| 3 | DANAHER CORP | 4.8% |
| 4 | MERCK & CO INC | 4.7% |
| 5 | THERMO FISHER SCIENTIFIC INC | 4.7% |
| 6 | JOHNSON & JOHNSON | 4.7% |
| 7 | AMGEN INC | 4.4% |
| 8 | STRYKER CORP | 4.3% |
| 9 | ASTRAZENECA PLC | 4.2% |
| 10 | VERTEX PHARMACEUTICALS INC | 4.1% |
Where to buy this fund
Where it trades
| Exchange | Ticker | Currency | |
|---|---|---|---|
| LSE | SDG3 | USD | ★ Primary |
| B3 | SDG3L | USD | |
| B3 | XDG3Z | USD | |
| B3 | XDG3M | USD | |
| B3 | XDG3L | USD | |
| B3 | XDG3D | USD | |
| Borsa Italiana | XDG3 | EUR | |
| BW | XDG3 | USD | |
| E1 | XDG3USD | USD | |
| E1 | XDG3GBP | USD | |
| E1 | XDG3EUR | USD | |
| E1 | XDG3CHF | USD | |
| EB | XDG3L | USD | |
| EB | XDG3Z | USD | |
| EB | XDG3D | USD | |
| EO | XDG3USD | USD | |
| EO | XDG3GBP | USD | |
| EO | XDG3EUR | USD | |
| EO | XDG3CHF | USD | |
| EP | XDG3EUR | USD | |
| EP | XDG3CHF | USD | |
| EU | XDG3CHF | USD | |
| EU | XDG3EUR | USD | |
| EU | XDG3GBP | USD | |
| EU | XDG3USD | USD | |
| EZ | XDG3EUR | USD | |
| EZ | XDG3CHF | USD | |
| Frankfurt | XDG3 | EUR | |
| GD | XDG3 | USD | |
| GF | XDG3 | USD | |
| GM | XDG3 | USD | |
| GS | XDG3 | USD | |
| GT | XDG3 | USD | |
| GZ | XDG3 | USD | |
| I2 | XDG3D | USD | |
| IX | XDG3D | USD | |
| IX | XDG3L | USD | |
| IX | XDG3Z | USD | |
| L1 | XDG3Z | USD | |
| L1 | XDG3M | USD | |
| L1 | XDG3L | USD | |
| L1 | XDG3D | USD | |
| L1 | SDG3L | USD | |
| L3 | XDG3Z | USD | |
| L3 | XDG3M | USD | |
| L3 | XDG3L | USD | |
| L3 | XDG3D | USD | |
| L3 | SDG3L | USD | |
| LA | XDG3 | USD | |
| LSE | XDG3 | USD | |
| LU | XDG3 | USD | |
| PO | SDG3L | USD | |
| PO | XDG3D | USD | |
| PO | XDG3L | USD | |
| PO | XDG3M | USD | |
| PO | XDG3Z | USD | |
| QT | XDG3 | USD | |
| S1 | XDG3Z | USD | |
| S1 | XDG3L | USD | |
| S1 | XDG3D | USD | |
| S4 | XDG3D | USD | |
| SE | XDG3 | USD | |
| SIX | XDG3 | CHF | |
| TH | XDG3 | USD | |
| X1 | XDG3USD | USD | |
| X1 | XDG3GBP | USD | |
| X1 | XDG3EUR | USD | |
| X1 | XDG3CHF | USD | |
| X2 | XDG3CHF | USD | |
| X2 | XDG3EUR | USD | |
| X2 | XDG3GBP | USD | |
| X2 | XDG3USD | USD | |
| X9 | XDG3EUR | USD | |
| XA | XDG3USD | USD | |
| XA | XDG3GBP | USD | |
| XA | XDG3EUR | USD | |
| XA | XDG3CHF | USD | |
| XE | XDG3CHF | USD | |
| XE | XDG3EUR | USD | |
| XE | XDG3GBP | USD | |
| XE | XDG3USD | USD | |
| XF | XDG3USD | USD | |
| XF | XDG3GBP | USD | |
| XF | XDG3EUR | USD | |
| XF | XDG3CHF | USD | |
| XG | XDG3CHF | USD | |
| XG | XDG3EUR | USD | |
| XG | XDG3GBP | USD | |
| XG | XDG3USD | USD | |
| XH | XDG3USD | USD | |
| XH | XDG3GBP | USD | |
| XH | XDG3EUR | USD | |
| XH | XDG3CHF | USD | |
| XJ | XDG3CHF | USD | |
| XJ | XDG3EUR | USD | |
| XJ | XDG3GBP | USD | |
| XJ | XDG3USD | USD | |
| XL | XDG3USD | USD | |
| XL | XDG3GBP | USD | |
| XL | XDG3EUR | USD | |
| XL | XDG3CHF | USD | |
| XO | XDG3CHF | USD | |
| XO | XDG3EUR | USD | |
| XO | XDG3GBP | USD | |
| XO | XDG3USD | USD | |
| XQ | XDG3USD | USD | |
| XQ | XDG3GBP | USD | |
| XQ | XDG3EUR | USD | |
| XQ | XDG3CHF | USD | |
| XT | XDG3EUR | USD | |
| XU | XDG3CHF | USD | |
| XU | XDG3EUR | USD | |
| XU | XDG3GBP | USD | |
| XU | XDG3USD | USD | |
| XV | XDG3USD | USD | |
| XV | XDG3GBP | USD | |
| XV | XDG3EUR | USD | |
| XV | XDG3CHF | USD | |
| XW | XDG3CHF | USD | |
| XW | XDG3EUR | USD | |
| XW | XDG3GBP | USD | |
| XW | XDG3USD | USD | |
| XX | XDG3USD | USD | |
| XX | XDG3GBP | USD | |
| XX | XDG3EUR | USD | |
| XX | XDG3CHF | USD | |
| XY | XDG3USD | USD | |
| XY | XDG3GBP | USD | |
| XY | XDG3EUR | USD | |
| XY | XDG3CHF | USD | |
| XZ | XDG3CHF | USD | |
| XZ | XDG3EUR | USD | |
| XZ | XDG3GBP | USD | |
| XZ | XDG3USD | USD |
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows
Full holdings
As of 2026-07-17 · the fund's own published holdings.
| # | Company | Weight |
|---|---|---|
| 1 | ELI LILLY | 5.0% |
| 2 | ABBVIE INC | 4.9% |
| 3 | DANAHER CORP | 4.8% |
| 4 | MERCK & CO INC | 4.7% |
| 5 | THERMO FISHER SCIENTIFIC INC | 4.7% |
| 6 | JOHNSON & JOHNSON | 4.7% |
| 7 | AMGEN INC | 4.4% |
| 8 | STRYKER CORP | 4.3% |
| 9 | ASTRAZENECA PLC | 4.2% |
| 10 | VERTEX PHARMACEUTICALS INC | 4.1% |
| 11 | GILEAD SCIENCES INC | 4.0% |
| 12 | NOVO NORDISK CLASS B | 3.8% |
| 13 | BRISTOL MYERS SQUIBB | 3.6% |
| 14 | AGILENT TECHNOLOGIES INC | 2.6% |
| 15 | ABBOTT LABORATORIES | 2.6% |
| 16 | GLAXOSMITHKLINE | 2.3% |
| 17 | SANOFI SA | 2.3% |
| 18 | GE HEALTHCARE TECHNOLOGIES INC | 2.1% |
| 19 | REGENERON PHARMACEUTICALS INC | 1.8% |
| 20 | MEDTRONIC PLC | 1.7% |
| 21 | ARGENX | 1.7% |
| 22 | RESMED INC | 1.6% |
| 23 | EDWARDS LIFESCIENCES CORP | 1.5% |
| 24 | BOSTON SCIENTIFIC CORP | 1.1% |
| 25 | ALNYLAM PHARMACEUTICALS INC | 1.0% |
| 26 | DEXCOM INC | 0.9% |
| 27 | CSL LTD | 0.8% |
| 28 | KIMBERLY CLARK CORP | 0.8% |
| 29 | MODERNA INC | 0.7% |
| 30 | CHUGAI PHARMACEUTICAL LTD | 0.7% |
| 31 | INSMED INC | 0.7% |
| 32 | UNITED THERAPEUTICS CORP | 0.7% |
| 33 | BIO TECHNE CORP | 0.6% |
| 34 | QIAGEN NV | 0.6% |
| 35 | BEONE MEDICINES AG | 0.5% |
| 36 | INCYTE CORP | 0.5% |
| 37 | DAIICHI SANKYO LTD | 0.5% |
| 38 | NEUROCRINE BIOSCIENCES INC | 0.5% |
| 39 | BAXTER INTERNATIONAL INC | 0.5% |
| 40 | LANTHEUS HOLDINGS INC | 0.5% |
| 41 | HIMS HERS HEALTH INC CLASS A | 0.4% |
| 42 | GENMAB | 0.4% |
| 43 | JAZZ PHARMACEUTICALS PLC | 0.4% |
| 44 | TELEFLEX INC | 0.4% |
| 45 | BIO RAD LABORATORIES INC CLASS A | 0.4% |
| 46 | EXELIXIS INC | 0.4% |
| 47 | INNOVENT BIOLOGICS INC | 0.4% |
| 48 | PHARMAESSENTIA CORP | 0.4% |
| 49 | INSULET CORP | 0.3% |
| 50 | SONOVA HOLDING AG | 0.3% |
| 51 | ESSITY CLASS B | 0.3% |
| 52 | BIOMARIN PHARMACEUTICAL INC | 0.3% |
| 53 | AXSOME THERAPEUTICS INC | 0.3% |
| 54 | MASCO CORP | 0.3% |
| 55 | SHIONOGI LTD | 0.3% |
| 56 | CORCEPT THERAPEUTICS INC | 0.3% |
| 57 | VERACYTE INC | 0.3% |
| 58 | ICU MEDICAL INC | 0.2% |
| 59 | SWEDISH ORPHAN BIOVITRUM | 0.2% |
| 60 | ONO PHARMACEUTICAL LTD | 0.2% |
| 61 | IPSEN SA | 0.2% |
| 62 | TRAVERE THERAPEUTICS INC | 0.2% |
| 63 | UNICHARM CORP | 0.1% |
| 64 | LOUISIANA PACIFIC CORP | 0.1% |
| 65 | EISAI LTD | 0.1% |
| 66 | HAEMONETICS CORP | 0.1% |
| 67 | INDIVIOR PHARMACEUTICALS INC | 0.1% |
| 68 | IRHYTHM HOLDINGS INC | 0.1% |
| 69 | TOTO LTD | 0.1% |
| 70 | COCHLEAR LTD | 0.1% |
| 71 | LIGAND PHARMACEUTICALS INC | 0.1% |
| 72 | ASAHI INTECC LTD | 0.1% |
| 73 | ELEKTA CLASS B | 0.1% |
| 74 | SUMITOMO PHARMA LTD | 0.1% |
| 75 | NEOGENOMICS INC | 0.1% |
| 76 | TELADOC HEALTH INC | 0.1% |
| 77 | RECORDATI INDUSTRIA CHIMICA E FARM | 0.1% |
| 78 | SHENZHEN MINDRAY BIO-MEDICAL ELECT | 0.1% |
| 79 | DIASORIN | 0.1% |
| 80 | QUIDELORTHO CORP | 0.1% |
| 81 | INTEGRA LIFESCIENCES HOLDINGS CORP | 0.1% |
| 82 | MERIT MEDICAL SYSTEMS INC | 0.1% |
| 83 | KYOWA KIRIN LTD | 0.1% |
| 84 | HANSOH PHARMACEUTICAL GROUP LTD | 0.1% |
| 85 | KIMBERLY-CLARK DE MEXICO CLASS A | 0.1% |
| 86 | CATALYST PHARMACEUTICALS INC | 0.1% |
| 87 | LIVANOVA PLC | 0.1% |
| 88 | NIPRO CORP | 0.1% |
| 89 | AGIOS PHARMACEUTICALS INC | 0.1% |
| 90 | DEMANT | 0.1% |
| 91 | INTERFACE INC | 0.1% |
| 92 | ZAI LAB LTD | 0.1% |
| 93 | NIHON KOHDEN CORP | 0.1% |
| 94 | HARMONY BIOSCIENCES HLDG INC | 0.1% |
| 95 | H. LUNDBECK CLASS B | 0.1% |
| 96 | CONMED CORP | 0.1% |
| 97 | HENGAN INTERNATIONAL GROUP LTD | 0.1% |
| 98 | SYNDAX PHARMACEUTICALS INC | 0.0% |
| 99 | ATRICURE INC | 0.0% |
| 100 | AMYLYX PHARMACEUTICALS INC | 0.0% |
| 101 | ULTRAGENYX PHARMACEUTICAL INC | 0.0% |
| 102 | BIOARCTIC CLASS B | 0.0% |
| 103 | XERIS BIOPHARMA HOLDINGS INC | 0.0% |
| 104 | CAREDX INC | 0.0% |
| 105 | TANDEM DIABETES CARE INC | 0.0% |
| 106 | MICROPORT SCIENTIFIC CORP | 0.0% |
| 107 | DRAEGERWERK PREF AG | 0.0% |
| 108 | PING AN HEALTHCARE AND TECHNOLOGY | 0.0% |
| 109 | PHARMING GROUP NV | 0.0% |
| 110 | JAPANESE YEN | 0.0% |
| 111 | AMPLIFON | 0.0% |
| 112 | CHINA MEDICAL SYSTEM HOLDINGS LTD | 0.0% |
| 113 | PHARMA MAR SA | 0.0% |
| 114 | NEW TAIWAN DOLLAR | 0.0% |
| 115 | MANNKIND CORP | 0.0% |
| 116 | LIFETECH SCIENTIFIC CORP | 0.0% |
| 117 | ARTIVION INC | 0.0% |
| 118 | SOUTH KOREAN WON | 0.0% |
| 119 | DANISH KRONE | 0.0% |
| 120 | ONENESS BIOTECH LTD | 0.0% |
| 121 | SWEDISH KRONA | 0.0% |
| 122 | SWISS FRANC | 0.0% |
| 123 | HONG KONG DOLLAR | 0.0% |
| 124 | AUSTRALIAN DOLLAR | 0.0% |
| 125 | EURO CURRENCY | 0.0% |
| 126 | POUND STERLING | 0.0% |
| 127 | YUAN RENMINBI | 0.0% |
| 128 | MEXICAN PESO (NEW) | 0.0% |
| 129 | CANADIAN DOLLAR | 0.0% |
| 130 | - | 0.0% |
| 131 | US DOLLAR | 0.0% |
How it ranks vs peers
Versus the Equity (stocks) · Global · GBP ETFs we track.
Advanced risk
Concentration depth
Roughly 131 companies are held, but the largest names carry most of the weight — so it behaves like ~33 equal-sized positions.
Tilt vs a world tracker
Percentage points over / under a broad world-equity tracker (not a licensed benchmark).
Similar funds
We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.
| Xtrackers MSCI Global Sdg 3 Good Health UCITS ETF 1CXtrackersYou're viewing | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | State Street® SPDR® Portfolio Developed World ex-US ETFSPDRBroader match | iShares MSCI ACWI UCITS ETFiSharesBroader match | |
|---|---|---|---|---|---|---|---|
| Why it's similar | This is the fund on this page. | StocksPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. | StocksUnknownPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. |
| Index tracked | MSCI Global Sdg 3 Good Health | MSCI World | MSCI World | MSCI World | MSCI World | S&P Developed Ex-U.S. BMI Index | MSCI ACWI |
| Yearly fee (TER) | 0.00% | 0.30% | 0.30% | 0.20% | 0.20% | 0.03% | 0.20% |
| All-in cost | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Fund size | €0 | €171.5B | €146.5B | €128.1B | €128.1B | €35B | €30.7B |
| Domicile | Ireland | Ireland | Ireland | Ireland | United States | Ireland | |
| Replication | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) |
| 3-yr return p.a. | +5.9% | +17.2% | +17.8% | +19.4% | +13.8% | ||
| 5-yr return p.a. | +10.1% | +9.3% | +11.4% | +6.3% | |||
| # holdings | 131 | 1,356 | 1,356 | 1,356 | 1,356 | 2,469 | 1,738 |
The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.
Open the full comparison tool →New to ETFs? Start with the basics →
Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.